ライフサイエンスコーパス: catheterization

1 al fibrillation on OAC who underwent cardiac catheterization.

2 s >=70 years old or with diabetes or urinary catheterization.

3 cia stuartii, commonly occurs with long-term catheterization.

4 ause mortality over 90 days and 1 year after catheterization.

5 ical Coherence Tomography during Right Heart catheterization.

6 dial artery becomes obstructed after cardiac catheterization.

7 ngle and multi-use) package for intermittent catheterization.

8 ata regarding race or the diagnostic cardiac catheterization.

9 years old and undergoing diagnostic cardiac catheterization.

10 f upper-extremity function after transradial catheterization.

11 gnetic resonance imaging and pressure volume catheterization.

12 s of imaging-guided transhepatic intraportal catheterization.

13 234 patients undergoing transradial cardiac catheterization.

14 cline in excess mortality associated with PA catheterization.

15 ut definitive diagnosis requires right-heart catheterization.

16 ght be damaged after cannulation for cardiac catheterization.

17 inpatient status at the time of right heart catheterization.

18 in coronary artery bypass grafting after its catheterization.

19 echocardiography when compared with cardiac catheterization.

20 nexplained dyspnea who underwent right heart catheterization.

21 eumothorax than jugular-vein or femoral-vein catheterization.

22 s of interest included safety and failure of catheterization.

23 k in a cohort of patients undergoing cardiac catheterization.

24 comes in children with PH undergoing cardiac catheterization.

25 rdiac treatments, and outcomes after cardiac catheterization.

26 method previously validated against cardiac catheterization.

27 with atrial fibrillation undergoing cardiac catheterization.

28 ry of sequential patients undergoing cardiac catheterization.

29 prevalent among patients undergoing cardiac catheterization.

30 rformed on frozen fasting plasma obtained at catheterization.

31 y both echocardiography and right/left heart catheterization.

32 nsthoracic echocardiography, and right heart catheterization.

33 cess route commonly used in pulmonary artery catheterization.

34 mind before common interventions such as UV catheterizations.

35 btained in 85 patients during a total of 829 catheterizations.

36 tract infections and need for transient self-catheterizations.

37 , reporting 655 patients, 757 eyes, and 2350 catheterizations.

38 with serial echocardiograms and right heart catheterizations.

39 isk-adjusted odds ratio for mortality for PA catheterization, 1.66 (95% confidence interval, 1.60-1.7

40 per 1000 CHD patients in diagnostic cardiac catheterizations (11.7 to 13.7 per 1000), structural hea

41 try from 2013 to 2016, 741 underwent cardiac catheterization (139 with percutaneous coronary interven

42 ively all US veterans undergoing right heart catheterization (2007-2012) in the Veterans Affairs heal

43 In patients with right heart catheterization (30 HF-PH, 14 PVOD), similar association

44 Participants underwent a second catheterization 4 weeks later for measurement of dP/dt.

45 associated with more revascularizations and catheterizations (4.25 per 100 patients) with CTA use.

46 f six independent predictors: central venous catheterization (5 points), immobilization greater than

47 6%) and those with diabetes (43%) or urinary catheterization (60%).

48 After catheterization, a transvenous pacing catheter was place

49 -one adult Fontan patients underwent cardiac catheterization; age 26+/-3 years, men 146 (56%), atriop

50 ents, five of which had multiple right heart catheterizations allowing an assessment of cardiac funct

51 ling from a new catheter or sterile straight catheterization, along with urine bacteria and pyuria sc

52 Together, these data suggest that catheterization alters the urinary tract environment to

53 V pressure-volume relationships, right heart catheterization and 3-dimensional echocardiography were

54 rization as assessed by closed-chest cardiac catheterization and anti-alphaSMA staining.

55 long-axis view for subclavian central venous catheterization and avoiding posterior wall penetrations

56 measurements were assessed using right heart catheterization and cardiac MRI.

57 COPD patients who underwent both right heart catheterization and computed tomography in a period of s

58 participants who underwent both right heart catheterization and dual-phase dual-energy CT pulmonary

59 catheter system is feasible for renal artery catheterization and embolization under real-time MR imag

60 educe the risks associated with conventional catheterization and enable continuous non-invasive point

61 undergoing simultaneous right and left heart catheterization and estimated associations of eGFR with

62 with invasive procedures such as right heart catheterization and histopathology.

63 riteria included the need for urgent cardiac catheterization and history of ACS or coronary revascula

64 he renal vein of patients undergoing cardiac catheterization and identified glycerol-3-phosphate (G-3

65 Central venous catheterization and immobilization are potentially modif

66 s in 54 pediatric PH patients during cardiac catheterization and in 54 matched controls.

67 s in 78 pediatric PH patients during cardiac catheterization and in 78 matched controls.

68 and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric and adult

69 within 24 hours of a diagnostic right heart catheterization and invasive measurement of RV pressure-

70 therapy; patients also underwent right-heart catheterization and LSM at these time points.

71 rwent detailed reassessment with right heart catheterization and noninvasive testing at 3 to 6 months

72 analysis of data collected in the Diagnostic Catheterization and Percutaneous Coronary Intervention (

73 aring operator radiation dose during cardiac catheterization and percutaneous coronary intervention (

74 tal quality programs: 1) CathPCI (Diagnostic Catheterization and Percutaneous Coronary Intervention)

75 erator radiation dose during routine cardiac catheterization and percutaneous coronary intervention.

76 risk stratification of patients for cardiac catheterization and possible percutaneous coronary inter

77 siological assessment with right-sided heart catheterization and radionuclide ventriculography at res

78 Prompt coronary catheterization and revascularization have markedly impr

79 V affected patients received less aggressive catheterization and revascularization management after A

80 d by concurrent echocardiography and cardiac catheterization and traditionally does not account for p

81 emodynamic variables obtained by right heart catheterization and transpulmonary thermodilution measur

82 (Acute Catheterization and Urgent Intervention Triage Strategy

83 ocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy

84 All patients from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy)

85 s in Myocardial Infarction [TIMI], and Acute Catheterization and Urgent Intervention Triage) and requ

86 dient agreement between echocardiography and catheterization and was associated with a measurable dec

87 ic resonance (MR) imaging, right-sided heart catheterization, and 6-minute walk testing with a median

88 cardiac magnetic resonance imaging, cardiac catheterization, and echocardiography) and indexed to bo

89 iplatelet therapy (44.0% versus 41.3%) after catheterization, and had similar rates of myocardial inf

90 d in 54 pediatric PH patients during cardiac catheterization, and in 54 matched controls.

91 erformed baseline echocardiographic, cardiac catheterization, and serum NT-pro-BNP analysis in patien

92 NB due to SCI, using clean intermittent self-catheterization, and suffering from R-UTIs.

93 NB due to SCI, using clean intermittent self-catheterization, and suffering from R-UTIs.

94 rimary outcome measure was agreement between catheterization- and echocardiography-derived mean gradi

95 Women veterans undergoing catheterization are younger, have more obesity, depressi

96 , including echocardiography and right heart catheterization, are key elements in the assessment.

97 of age with PH undergoing 1 or more cardiac catheterization at centers participating in the Pediatri

98 Patients underwent right-heart catheterization at rest and during exercise at baseline

99 networks to provide around-the-clock cardiac catheterization availability and the generation of stand

100 on sequences were used for MR imaging-guided catheterization, balloon dilation, and stent implantatio

101 opted as the primary access site for cardiac catheterization because of patient preference, lower ble

102 us for all patients referred for right heart catheterization between 1998 and 2014.

103 ergoing diagnostic or interventional cardiac catheterization between January 2011 and March 2013.

104 Contrast media administered during cardiac catheterization can affect hemodynamic variables.

105 f an entire guide wire during central venous catheterization can lead to serious patient harm and req

106 or adverse outcomes after congenital cardiac catheterization can support reporting of risk-adjusted o

107 ncidence with increased frequency of cardiac catheterization (CATH) in liver transplant (LT) candidat

108 =6]) were evaluated monthly with right heart catheterization, CMR, and computed tomography during 4 m

109 trasound-assisted right-sided central venous catheterization compared with 92 serial historic control

110 Right heart catheterization confirmed constrictive physiology in all

111 Right heart catheterization data from clinical records of heart tran

112 ndrome who had complete baseline right heart catheterization data from the Fluid and Catheter Treatme

113 ure, we retrospectively assessed right heart catheterization data in 162 consecutive patients with ou

114 Among cases with available catheterization data pre- and post-CQI, the coverage pro

115 Echocardiographic and catheterization data were obtained during routine care.

116 is echocardiography studies with concomitant catheterization data, and deidentified individual and gr

117 During 2001 to 2006, PA catheterization declined across hospitals; however, in 2

118 ived CI (r=0.7; P<0.001), as well as cardiac catheterization-derived CI (r=0.6; P<0.001).

119 h a prespecified acceptable echocardiography-catheterization difference of <10 mm Hg in mean gradient

120 years of age presenting for routine cardiac catheterization during 2015 to 2016.

121 ve hemodynamic ramp testing with right heart catheterization, during which LVAD speeds were adjusted.

122 ongestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) trial were included (n =

123 ongestive Heart Failure and Pulmonary Artery Catheterization Effectiveness], CHARM [Candesartan in He

124 ral anticoagulation (OAC) undergoing cardiac catheterization face risks for embolic and bleeding even

125 four patients undergoing nonemergent cardiac catheterization followed by treatment (ie, 128 coronary

126 obtained from 50 patients undergoing cardiac catheterization for clinical indications.

127 rence of a major adverse event after cardiac catheterization for congenital heart disease.

128 the study period, 136 patients underwent 139 catheterizations for attempted Melody TPVR with a median

129 atients underwent biventricular EMB, cardiac catheterization (for exclusion of coronary artery diseas

130 ion included corticosteroid use, right heart catheterization, fungal infection, vasopressor use, and

131 (n = 4,742) were identified in the CATHGEN (Catheterization Genetics) biorepository of sequential pa

132 ry interventions, AKI was more common in the catheterization group (11.9%; 95% CI: 8%, 19%) than in t

133 %, 10%) and in 21 of 159 participants in the catheterization group (13.2%; 95% CI: 9%,19%) (relative

134 oup (84.3 mL/min/1.73 m(2) +/- 17.2) and the catheterization group (87.1 mL/min/1.73 m(2) +/- 16.7) (

135 Invasive central venous line catheterization has always been the gold standard method

136 ough ultrasound guidance for subclavian vein catheterization has been well described, evidence for it

137 hen culturing urine obtained by "in-and-out" catheterization in a selected female population.

138 ompared to landmark technique for subclavian catheterization in adult populations were considered.

139 ation procedure was performed before cardiac catheterization in all patients, except for those (n=78,

140 )]apelin-13 were assessed by MRI and cardiac catheterization in anesthetized rats.

141 The risk of cardiac catheterization in children and young adults with PH is

142 low-dose UFH (50 U/kg bolus) during cardiac catheterization in children.

143 substantial hospital-level variability in PA catheterization in HF along with increasing volume at fe

144 ions Using simultaneous echocardiography and catheterization in the largest study population to date,

145 ears; 3.3% female) who underwent right heart catheterization in this cohort study, Td and eFick CI es

146 than 15000 adults who underwent right heart catheterization, including 12232 in the Veterans Affairs

147 efficacy of the MXPD during routine cardiac catheterization, including percutaneous coronary interve

148 ed a mouse model of CAUTI to investigate how catheterization increases an individual's susceptibility

149 ltrasound-guided right internal jugular vein catheterization is exceedingly low.

150 ltrasound-guided right internal jugular vein catheterization is exceedingly low.

151 for adverse events after congenital cardiac catheterization is needed to equitably compare patient o

152 Cardiac output during cardiac catheterization is often estimated using the modified Fi

153 , Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

154 data on all CAs and PCIs performed in the 36 catheterization laboratories in the Greater Paris Area,

155 Interventional cardiologists at 2 cardiac catheterization laboratories within the same health syst

156 ty improvement activity performed in cardiac catheterization laboratories, but best practices for cas

157 Catheterization laboratory (cath lab) activation time is

158 sfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI recei

159 vel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorporeal life

160 y care processes increased after prehospital catheterization laboratory activation (62%-91%; P<0.001)

161 ), a first medical contact to device time to catheterization laboratory activation of </=20 minutes (

162 l infarction networks focused on prehospital catheterization laboratory activation, single call trans

163 ference between the patient's arrival at the catheterization laboratory and the patient's final angio

164 chemia will be the gatekeeper to the cardiac catheterization laboratory and will transform the world

165 minus the time between hospital arrival and catheterization laboratory arrival.

166 95% CI: 1.065 to 2.069), and treatment in a catheterization laboratory as opposed to hybrid operatin

167 We included all patients presenting to the catheterization laboratory at our institution after PMI

168 unctional LVOT conduit were evaluated in the catheterization laboratory between December 2008 and Aug

169 Particular adaptations to the cardiac catheterization laboratory environment are required to a

170 pulmonary resuscitation [CPR] to the cardiac catheterization laboratory for ECPR) compared with 654 a

171 ecutive patients referred to the Mayo Clinic catheterization laboratory for hemodynamic assessment be

172 tcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarction sus

173 s classified according to PCI center status (catheterization laboratory immediately accessible 24/7).

174 l process for developing an HOR in a cardiac catheterization laboratory in a VA designated for comple

175 these patients, early access to the cardiac catheterization laboratory is associated with a 10% to 1

176 site visit consisting of a National Chief of Catheterization Laboratory Managers, a cardiac surgeon,

177 procedural predictors were total time in the catheterization laboratory or operating room, delivery c

178 The catheterization laboratory protocol provides a model to

179 o-invasive strategy, and the risk of cardiac catheterization laboratory provider infection remained v

180 the median time from arrival in the cardiac catheterization laboratory to first balloon was 27 minut

181 In the catheterization laboratory, intravascular imaging provid

182 revascularization is now commonplace in the catheterization laboratory, the presence of a CTO provid

183 siological coronary lesion assessment in the catheterization laboratory, thereby potentially leading

184 number of clinicians are using a strategy of catheterization laboratory-only eptifibatide (an off-lab

185 A catheterization laboratory-only eptifibatide regimen is

186 alysis, compared with bolus plus infusion, a catheterization laboratory-only regimen was associated w

187 Of these, a catheterization laboratory-only regimen was used in 4511

188 olus plus infusion with those treated with a catheterization laboratory-only regimen.

189 dy supports the routine use of RADPAD in the catheterization laboratory.

190 s as to why we still need BMS in our cardiac catheterization laboratory.

191 in participants ascertained via the cardiac catheterization laboratory.

192 rdiopulmonary bypass or interventions in the catheterization laboratory.

193 ement of CI-AKI as it applies to the cardiac catheterization laboratory.

194 ot be recommended for decision making in the catheterization laboratory.

195 proaches of late or no access to the cardiac catheterization laboratory.

196 nd more than one-half do not have a coronary catheterization laboratory.

197 fits from therapies available in the cardiac catheterization laboratory.

198 nt, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI system

199 reduction were implemented in the pediatric catheterization labs of the C3PO-QI institutions.

200 within 72 hours after diagnostic left heart catheterization (LHC; primary end point).

201 ent demographic characteristics, right heart catheterization, mechanical circulatory support use, and

202 es at echocardiography and right-sided heart catheterization, medications, chronic lung disease, blee

203 with atrial fibrillation undergoing cardiac catheterization, most cases are elective, performed by f

204 echocardiographically (n=23) and by cardiac catheterization (n=5) after primary repair (n=4) or afte

205 Costs derived from outpatient catheterizations not in Pediatric Health Information Sys

206 AND Acute infarction was induced by cardiac catheterization of domestic swine.

207 Catheterization of the OA should be attempted from an os

208 Each rat underwent catheterization of the right femoral artery and left fem

209 wall, specialized imaging equipment, bladder catheterization or costly surgical equipment.

210 , intravascular procedures, including venous catheterization or injection.

211 d femoral access in women undergoing cardiac catheterization or percutaneous coronary intervention (P

212 -comer trial, patients undergoing diagnostic catheterization or percutaneous coronary interventions w

213 There was no significant difference in catheterizations or MRI scans.

214 3.7 [95% CI, 3.1-4.4]) and prior right heart catheterization (OR, 3.8 [95% CI, 3.4-4.3]).

215 cally significant lower procedural rates for catheterization (OR: 0.62, 95% CI: [0.52, 0.73]), PCI (O

216 n of HF patients undergoing pulmonary artery catheterization (PAC).

217 ion (10%), and rarely in unrelated real-life catheterization patients (6%).

218 reference central BP waveforms from cardiac catheterization patients.

219 tes were found compared to control group for catheterization, PCI and CABG (respectively OR: 0.90, 95

220 imary outcome), invasive management (cardiac catheterization, PCI, or CABG), revascularization (PCI o

221 Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI

222 ina) to compare rates of cardiac procedures (Catheterization, Percutaneous Coronary Intervention - PC

223 There was greater ST-segment resolution post-catheterization/percutaneous coronary intervention with

224 e hemodynamic evaluation through right heart catheterization plays an essential role in the diagnosis

225 Here, we introduce a catheterization procedure that keeps a rat physiological

226 complications related to diagnostic cardiac catheterization procedures are extremely rare.

227 scheduled for electrophysiology and cardiac catheterization procedures.

228 The C3PO-QI (Congenital Cardiac Catheterization Project on Outcomes - Quality Improvemen

229 VDOMICS study, the comprehensive right heart catheterization protocol described here holds promise to

230 After catheterization, radial artery puncture site is associat

231 e who suffered mucosal injuries via urethral catheterization, rarely showed evidence of neutrophil in

232 from the 4 member centers of the Congenital Catheterization Research Collaborative.

233 2008 to 2015 at 4 centers of the Congenital Catheterization Research Collaborative.

234 nce imaging, and pressure-volume conductance catheterization revealed impaired cardiac function in 2-

235 with normal mPAP) who underwent right heart catheterization (RHC) and three-directional phase-contra

236 underwent cardiac MRI and right-sided heart catheterization (RHC) between 2012 and 2016 were retrosp

237 arcoidosis and SAPH confirmed by right heart catheterization (RHC) were identified from 1990-2010.

238 testing, V/Q scanning, CTPA, and right heart catheterization (RHC) were prospectively obtained.

239 alue of at least 25 mm Hg during right heart catheterization (RHC).

240 d 2016 who had a follow-up right-sided heart catheterization (RHC).

241 ients are followed with periodic right heart catheterizations (RHCs) to identify post-transplant comp

242 ombined melphalan plus topotecan; P < 0.05), catheterization route (internal carotid artery vs. exter

243 Right heart catheterization showed severe precapillary PH with a mea

244 CTA was associated with fewer catheterizations showing no obstructive CAD than was fun

245 A: 36.5% versus 8.4%, OR, 5.95; P<0.001) and catheterization (stress: 5.5% versus 2.4%, OR, 2.36; CTA

246 in vivo echocardiography and pressure-volume catheterization studies revealed impaired systolic funct

247 Simultaneous echocardiographic-catheterization studies were prospectively conducted at

248 somewhat higher than, measures derived from catheterization studies.

249 ollow-up duration of 1 year, 13.3% underwent catheterization, surgery, or both, unrelated to infectio

250 kidney injury was more common after cardiac catheterization than after CT angiography in this prospe

251 is a thrombotic complication of transradial catheterization that can lead to permanent occlusion of

252 condary end points included invasive cardiac catheterization that did not show obstructive CAD and ra

253 Mean catheterization time with MR guidance was 93 seconds +/-

254 ndling was rated on a three-point scale, and catheterization times for different vessel regions were

255 Afterward, handling ratings and catheterization times were obtained for standard nitinol

256 dvanced heart failure undergoing right heart catheterization to assess cardiac transplantation candid

257 ural changes of the radial artery wall after catheterization to understand whether these might predic

258 terior communicating artery; P < 0.001), and catheterization type (occlusive into the ophthalmic arte

259 l therapy with a sham procedure (right heart catheterization) versus medical therapy and PFO closure

260 r 2014, 42 patients underwent 47 attempts at catheterization via PCA.

261 nd coronary artery disease underwent cardiac catheterization via radial access and performed incremen

262 not routinely required for pediatric cardiac catheterization via the carotid artery.

263 netic resonance imaging was 1.82, by cardiac catheterization was 1.65, and by echo was 1.7 L.min(-1).

264 n 2001, the number of hospitals with >/=1 PA catheterization was 1753, decreasing to 1183 in 2011.

265 Freedom from interventional catheterization was 53% at 15 years and 50% at 20 years.

266 The need for self-catheterization was 8% and 2% at 1 and 6 months in the o

267 ar risk factors, the main reason for cardiac catheterization was an acute coronary syndrome (n=54).

268 Failure of catheterization was analyzed with inverse variance rando

269 In this trial, subclavian-vein catheterization was associated with a lower risk of bloo

270 Cardiac catheterization was common (71% and 51%), but percutaneo

271 a major adverse event or death after cardiac catheterization was derived in 70% of the cohort and val

272 Among experienced operators, catheterization was faster with x-ray guidance (20 secon

273 uded in multivariate analysis, and occlusive catheterization was identified as an independent risk fa

274 egrees C heating) and MRI-guided right heart catheterization was performed in seven study participant

275 A single cardiac catheterization was performed on each patient with CO es

276 Right heart catheterization was performed using a pressure and Doppl

277 This analysis revealed that catheterization was required for MRSA to achieve high-le

278 Intranodal lymphangiogram and thoracic duct catheterization was successful in all patients.

279 al assays (including ileectomy and bile duct catheterization), we identify KLF15 as the first endogen

280 from 8,574 individuals referred for cardiac catheterization were analyzed.

281 tic stenosis and a preprocedural right heart catheterization were assessed.

282 Male Sprague-Dawley rats with jugular-vein catheterization were divided into three groups: no antic

283 thirty-seven patients undergoing transradial catheterization were enrolled.

284 ve patients within IMPACT undergoing cardiac catheterization were identified.

285 septal defects (ASD) that underwent cardiac catheterization were included.

286 l testing, echocardiography, and right heart catheterization were performed.

287 PVR) > 400 dyn s cm(-5) based on right heart catheterization were randomized to treatment with PADN (

288 A total of 19,608 cardiac catheterizations were performed between January 2011 and

289 cular EF (echocardiography) and then cardiac catheterization, where left ventricular pressure develop

290 from 2006 to 2014 as soon as they required a catheterization with a short-term central venous cathete

291 ith LGSAS and preserved EF underwent cardiac catheterization with comparison of hemodynamic measureme

292 h bioprosthetic TV dysfunction who underwent catheterization with planned TVIV.

293 subjects with HFpEF (n=26) underwent cardiac catheterization with simultaneous expired gas analysis a

294 trength MRI offers advantages for MRI-guided catheterizations with metal devices, MRI in high-suscept

295 stem, specifically MRI-guided cardiovascular catheterizations with metallic devices, diagnostic imagi

296 Of the 45 catheterizations with successful PCA and sheath placemen

297 A and 32 (16%) who had MPI underwent cardiac catheterization within 1 year.

298 azard ratio 1.96, P < 0.0001); (iii) urinary catheterization within 3 years of symptom onset (hazard

299 ts with hemodynamics measured by right heart catheterization within 30 days before left ventricular a

300 ugh more patients in the CTA group underwent catheterization within 90 days after randomization (12.2